2-methylsulfonyl-4-phenyl-3-(2H-tetrazol-5-yl)pyridine;3-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]benzamide;7-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]-4H-chromen-3-one;6-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]-1H-indazole;N-[4-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]phenyl]methanesulfonamide;4-[5-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]-2-pyridinyl]morpholine

C87H78N36O18S7 — CID 159495327

IUPAC2-methylsulfonyl-4-phenyl-3-(2H-tetrazol-5-yl)pyridine;3-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]benzamide;7-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]-4H-chromen-3-one;6-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]-1H-indazole;N-[4-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]phenyl]methanesulfonamide;4-[5-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]-2-pyridinyl]morpholine
SMILESCS(=O)(=O)Nc1ccc(-c2ccnc(S(C)(=O)=O)c2-c2nn[nH]n2)cc1.CS(=O)(=O)c1nccc(-c2ccc(N3CCOCC3)nc2)c1-c1nn[nH]n1.CS(=O)(=O)c1nccc(-c2ccc3c(c2)OCC(=O)C3)c1-c1nn[nH]n1.CS(=O)(=O)c1nccc(-c2ccc3cn[nH]c3c2)c1-c1nn[nH]n1.CS(=O)(=O)c1nccc(-c2cccc(C(N)=O)c2)c1-c1nn[nH]n1.CS(=O)(=O)c1nccc(-c2ccccc2)c1-c1nn[nH]n1
InChIInChI=1S/C16H17N7O3S.C16H13N5O4S.C14H11N7O2S.C14H14N6O4S2.C14H12N6O3S.C13H11N5O2S/c1-27(24,25)16-14(15-19-21-22-20-15)12(4-5-17-16)11-2-3-13(18-10-11)23-6-8-26-9-7-23;1-26(23,24)16-14(15-18-20-21-19-15)12(4-5-17-16)9-2-3-10-6-11(22)8-25-13(10)7-9;1-24(22,23)14-12(13-18-20-21-19-13)10(4-5-15-14)8-2-3-9-7-16-17-11(9)6-8;1-25(21,22)14-12(13-16-19-20-17-13)11(7-8-15-14)9-3-5-10(6-4-9)18-26(2,23)24;1-24(22,23)14-11(13-17-19-20-18-13)10(5-6-16-14)8-3-2-4-9(7-8)12(15)21;1-21(19,20)13-11(12-15-17-18-16-12)10(7-8-14-13)9-5-3-2-4-6-9/h2-5,10H,6-9H2,1H3,(H,19,20,21,22);2-5,7H,6,8H2,1H3,(H,18,19,20,21);2-7H,1H3,(H,16,17)(H,18,19,20,21);3-8,18H,1-2H3,(H,16,17,19,20);2-7H,1H3,(H2,15,21)(H,17,18,19,20);2-8H,1H3,(H,15,16,17,18)
InChIKeyLYSAQVJGCMIRRU-UHFFFAOYSA-N
MW2140.28 g/mol
LogP5.08
Rot. Bonds22

About 2-methylsulfonyl-4-phenyl-3-(2H-tetrazol-5-yl)pyridine;3-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]benzamide;7-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]-4H-chromen-3-one;6-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]-1H-indazole;N-[4-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]phenyl]methanesulfonamide;4-[5-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]-2-pyridinyl]morpholine

2-methylsulfonyl-4-phenyl-3-(2H-tetrazol-5-yl)pyridine;3-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]benzamide;7-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]-4H-chromen-3-one;6-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]-1H-indazole;N-[4-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]phenyl]methanesulfonamide;4-[5-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]-2-pyridinyl]morpholine (PubChem CID 159495327) has the molecular formula C87H78N36O18S7 and a molecular weight of 2140.28 g/mol. Its IUPAC name is 2-methylsulfonyl-4-phenyl-3-(2H-tetrazol-5-yl)pyridine;3-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]benzamide;7-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]-4H-chromen-3-one;6-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]-1H-indazole;N-[4-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]phenyl]methanesulfonamide;4-[5-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]-2-pyridinyl]morpholine.

Molecular Properties

Compound Name2-methylsulfonyl-4-phenyl-3-(2H-tetrazol-5-yl)pyridine;3-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]benzamide;7-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]-4H-chromen-3-one;6-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]-1H-indazole;N-[4-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]phenyl]methanesulfonamide;4-[5-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]-2-pyridinyl]morpholine
PubChem CID159495327
Molecular FormulaC87H78N36O18S7
Molecular Weight2140.28 g/mol
Exact Mass2138.43
IUPAC Name2-methylsulfonyl-4-phenyl-3-(2H-tetrazol-5-yl)pyridine;3-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]benzamide;7-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]-4H-chromen-3-one;6-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]-1H-indazole;N-[4-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]phenyl]methanesulfonamide;4-[5-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]-2-pyridinyl]morpholine
SMILESCS(=O)(=O)Nc1ccc(-c2ccnc(S(C)(=O)=O)c2-c2nn[nH]n2)cc1.CS(=O)(=O)c1nccc(-c2ccc(N3CCOCC3)nc2)c1-c1nn[nH]n1.CS(=O)(=O)c1nccc(-c2ccc3c(c2)OCC(=O)C3)c1-c1nn[nH]n1.CS(=O)(=O)c1nccc(-c2ccc3cn[nH]c3c2)c1-c1nn[nH]n1.CS(=O)(=O)c1nccc(-c2cccc(C(N)=O)c2)c1-c1nn[nH]n1.CS(=O)(=O)c1nccc(-c2ccccc2)c1-c1nn[nH]n1
InChIInChI=1S/C16H17N7O3S.C16H13N5O4S.C14H11N7O2S.C14H14N6O4S2.C14H12N6O3S.C13H11N5O2S/c1-27(24,25)16-14(15-19-21-22-20-15)12(4-5-17-16)11-2-3-13(18-10-11)23-6-8-26-9-7-23;1-26(23,24)16-14(15-18-20-21-19-15)12(4-5-17-16)9-2-3-10-6-11(22)8-25-13(10)7-9;1-24(22,23)14-12(13-18-20-21-19-13)10(4-5-15-14)8-2-3-9-7-16-17-11(9)6-8;1-25(21,22)14-12(13-16-19-20-17-13)11(7-8-15-14)9-3-5-10(6-4-9)18-26(2,23)24;1-24(22,23)14-11(13-17-19-20-18-13)10(5-6-16-14)8-3-2-4-9(7-8)12(15)21;1-21(19,20)13-11(12-15-17-18-16-12)10(7-8-14-13)9-5-3-2-4-6-9/h2-5,10H,6-9H2,1H3,(H,19,20,21,22);2-5,7H,6,8H2,1H3,(H,18,19,20,21);2-7H,1H3,(H,16,17)(H,18,19,20,21);3-8,18H,1-2H3,(H,16,17,19,20);2-7H,1H3,(H2,15,21)(H,17,18,19,20);2-8H,1H3,(H,15,16,17,18)
InChIKeyLYSAQVJGCMIRRU-UHFFFAOYSA-N
XLogP5.08
TPSA778.54 Ų
H-Bond Donors9
H-Bond Acceptors45
Rotatable Bonds22
Heavy Atoms148
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002140.28
LogP ≤ 55.08
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1045

Analyze 2-methylsulfonyl-4-phenyl-3-(2H-tetrazol-5-yl)pyridine;3-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]benzamide;7-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]-4H-chromen-3-one;6-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]-1H-indazole;N-[4-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]phenyl]methanesulfonamide;4-[5-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]-2-pyridinyl]morpholine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-methylsulfonyl-4-phenyl-3-(2H-tetrazol-5-yl)pyridine;3-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]benzamide;7-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]-4H-chromen-3-one;5-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]-1H-indazole;6-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]-1H-indazole;N-[4-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]phenyl]methanesulfonamide;4-[5-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]-2-pyridinyl]morpholine;5-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]-3-(trifluoromethyl)-1H-isoindole
CID 158302297
5-propan-2-yl-1-benzofuran;6-propan-2-yl-1-benzofuran;bis(5-propan-2-yl-1,3-benzothiazole);bis(6-propan-2-yl-1,3-benzothiazole);5-propan-2-yl-1H-indazole;bis(6-propan-2-yl-1H-indazole);5-propan-2-yl-1H-isoindole;6-propan-2-ylisoquinoline;7-propan-2-ylisoquinoline;2-propan-2-ylquinazoline;6-propan-2-ylquinazoline;7-propan-2-ylquinazoline;2-propan-2-ylquinoline;6-propan-2-ylquinoline;7-propan-2-ylquinoline
CID 158247897
6-ethoxy-N-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]quinazolin-4-amine;6-ethylsulfinyl-N-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]quinazolin-4-amine;1-methoxy-3-[4-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]quinazolin-6-yl]propan-2-one;1-methyl-3-[4-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]quinazolin-6-yl]imidazolidin-2-one;2-[4-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]quinazolin-6-yl]-1-(oxan-4-yl)ethanone;1-[2-[4-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]quinazolin-6-yl]oxyethyl]pyrrolidin-2-one
CID 159151204
1-[6-(1-benzofuran-5-yl)-[1,2,4]triazolo[1,5-a]pyridin-8-yl]-2-(4-methyl-1,3-thiazol-2-yl)ethanone;1-[6-(2,5-dimethyl-1H-pyrazol-2-ium-3-yl)-[1,2,4]triazolo[1,5-a]pyridin-8-yl]-2-(4-methyl-1,3-thiazol-2-yl)ethanone;1-[6-(3-methylphenyl)-[1,2,4]triazolo[1,5-a]pyridin-8-yl]-2-(4-methyl-1,3-thiazol-2-yl)ethanone;1-[6-(4-methyl-3-pyridinyl)-[1,2,4]triazolo[1,5-a]pyridin-8-yl]-2-(4-methyl-1,3-thiazol-2-yl)ethanone;2-(4-methyl-1,3-thiazol-2-yl)-1-(6-phenyl-[1,2,4]triazolo[1,5-a]pyridin-8-yl)ethanone;2-(4-methyl-1,3-thiazol-2-yl)-1-(6-pyridin-3-yl-[1,2,4]triazolo[1,5-a]pyridin-8-yl)ethanone;2-(4-methyl-1,3-thiazol-2-yl)-1-(6-quinolin-6-yl-[1,2,4]triazolo[1,5-a]pyridin-8-yl)ethanone
CID 160063441
bis(5-propan-2-yl-1-benzofuran);bis(6-propan-2-yl-1-benzofuran);bis(5-propan-2-yl-1,3-benzothiazole);bis(6-propan-2-yl-1,3-benzothiazole);5-propan-2-yl-1H-indazole;6-propan-2-yl-1H-indazole;6-propan-2-ylisoquinoline;7-propan-2-ylisoquinoline;2-propan-2-ylquinazoline;6-propan-2-ylquinazoline;7-propan-2-ylquinazoline;2-propan-2-ylquinoline;6-propan-2-ylquinoline;7-propan-2-ylquinoline
CID 160341026
2,6-dimethyl-N-[3-[4-(3-oxo-4H-1,4-benzoxazin-7-yl)phenyl]propyl]pyridine-3-carboxamide;2-methyl-N-[3-[4-(4-methyl-1H-indazol-5-yl)phenyl]propyl]benzamide;5-methyl-N-[3-[4-(4-methyl-1H-indazol-5-yl)phenyl]propyl]thiophene-2-carboxamide;2-methyl-N-[3-[4-(1H-pyrrolo[2,3-b]pyridin-5-yl)phenyl]propyl]benzamide;5-methyl-N-[3-[4-(1H-pyrrolo[2,3-b]pyridin-5-yl)phenyl]propyl]thiophene-2-carboxamide;N-[3-[4-(1H-pyrrolo[2,3-b]pyridin-5-yl)phenyl]propyl]pyridine-3-carboxamide
CID 165107399

Frequently Asked Questions

What is the IUPAC name of 2-methylsulfonyl-4-phenyl-3-(2H-tetrazol-5-yl)pyridine;3-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]benzamide;7-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]-4H-chromen-3-one;6-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]-1H-indazole;N-[4-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]phenyl]methanesulfonamide;4-[5-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]-2-pyridinyl]morpholine?
The IUPAC name of 2-methylsulfonyl-4-phenyl-3-(2H-tetrazol-5-yl)pyridine;3-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]benzamide;7-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]-4H-chromen-3-one;6-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]-1H-indazole;N-[4-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]phenyl]methanesulfonamide;4-[5-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]-2-pyridinyl]morpholine (CID 159495327) is 2-methylsulfonyl-4-phenyl-3-(2H-tetrazol-5-yl)pyridine;3-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]benzamide;7-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]-4H-chromen-3-one;6-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]-1H-indazole;N-[4-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]phenyl]methanesulfonamide;4-[5-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]-2-pyridinyl]morpholine.
What is the SMILES notation for 2-methylsulfonyl-4-phenyl-3-(2H-tetrazol-5-yl)pyridine;3-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]benzamide;7-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]-4H-chromen-3-one;6-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]-1H-indazole;N-[4-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]phenyl]methanesulfonamide;4-[5-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]-2-pyridinyl]morpholine?
The canonical SMILES for 2-methylsulfonyl-4-phenyl-3-(2H-tetrazol-5-yl)pyridine;3-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]benzamide;7-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]-4H-chromen-3-one;6-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]-1H-indazole;N-[4-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]phenyl]methanesulfonamide;4-[5-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]-2-pyridinyl]morpholine is CS(=O)(=O)Nc1ccc(-c2ccnc(S(C)(=O)=O)c2-c2nn[nH]n2)cc1.CS(=O)(=O)c1nccc(-c2ccc(N3CCOCC3)nc2)c1-c1nn[nH]n1.CS(=O)(=O)c1nccc(-c2ccc3c(c2)OCC(=O)C3)c1-c1nn[nH]n1.CS(=O)(=O)c1nccc(-c2ccc3cn[nH]c3c2)c1-c1nn[nH]n1.CS(=O)(=O)c1nccc(-c2cccc(C(N)=O)c2)c1-c1nn[nH]n1.CS(=O)(=O)c1nccc(-c2ccccc2)c1-c1nn[nH]n1.
What is the InChIKey of 2-methylsulfonyl-4-phenyl-3-(2H-tetrazol-5-yl)pyridine;3-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]benzamide;7-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]-4H-chromen-3-one;6-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]-1H-indazole;N-[4-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]phenyl]methanesulfonamide;4-[5-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]-2-pyridinyl]morpholine?
The InChIKey is LYSAQVJGCMIRRU-UHFFFAOYSA-N. The full InChI is InChI=1S/C16H17N7O3S.C16H13N5O4S.C14H11N7O2S.C14H14N6O4S2.C14H12N6O3S.C13H11N5O2S/c1-27(24,25)16-14(15-19-21-22-20-15)12(4-5-17-16)11-2-3-13(18-10-11)23-6-8-26-9-7-23;1-26(23,24)16-14(15-18-20-21-19-15)12(4-5-17-16)9-2-3-10-6-11(22)8-25-13(10)7-9;1-24(22,23)14-12(13-18-20-21-19-13)10(4-5-15-14)8-2-3-9-7-16-17-11(9)6-8;1-25(21,22)14-12(13-16-19-20-17-13)11(7-8-15-14)9-3-5-10(6-4-9)18-26(2,23)24;1-24(22,23)14-11(13-17-19-20-18-13)10(5-6-16-14)8-3-2-4-9(7-8)12(15)21;1-21(19,20)13-11(12-15-17-18-16-12)10(7-8-14-13)9-5-3-2-4-6-9/h2-5,10H,6-9H2,1H3,(H,19,20,21,22);2-5,7H,6,8H2,1H3,(H,18,19,20,21);2-7H,1H3,(H,16,17)(H,18,19,20,21);3-8,18H,1-2H3,(H,16,17,19,20);2-7H,1H3,(H2,15,21)(H,17,18,19,20);2-8H,1H3,(H,15,16,17,18).
What are the key properties of 2-methylsulfonyl-4-phenyl-3-(2H-tetrazol-5-yl)pyridine;3-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]benzamide;7-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]-4H-chromen-3-one;6-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]-1H-indazole;N-[4-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]phenyl]methanesulfonamide;4-[5-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]-2-pyridinyl]morpholine?
2-methylsulfonyl-4-phenyl-3-(2H-tetrazol-5-yl)pyridine;3-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]benzamide;7-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]-4H-chromen-3-one;6-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]-1H-indazole;N-[4-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]phenyl]methanesulfonamide;4-[5-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]-2-pyridinyl]morpholine has a molecular weight of 2140.28 g/mol, XLogP of 5.08, 22 rotatable bonds, 9 hydrogen bond donors, and 45 hydrogen bond acceptors.
Where does this data come from?
All data for 2-methylsulfonyl-4-phenyl-3-(2H-tetrazol-5-yl)pyridine;3-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]benzamide;7-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]-4H-chromen-3-one;6-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]-1H-indazole;N-[4-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]phenyl]methanesulfonamide;4-[5-[2-methylsulfonyl-3-(2H-tetrazol-5-yl)-4-pyridinyl]-2-pyridinyl]morpholine is sourced from PubChem (CID 159495327), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).